Clinical Trials
3 trialsNCT07223411 2025-11-26
Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma
University of Pittsburgh
Recruiting
NCT03836105 2025-10-15
CASE
Regeneron Pharmaceuticals
Completed
NCT07064330 2025-09-10
NGF-GRACE
Instituto de Investigación Biomédica de Salamanca
Recruiting